The first patient has been dosed in a Phase 1 trial testing the experimental CAR T-cell therapy obecabtagene autoleucel for progressive MS.
CAR T-cell therapy uses re-engineered immune cells to attack diseases. After proving its effectiveness on cancer patients, it ...
A biology teacher and mother-of-two has become the first UK patient to receive a "gamechanger" therapy to treat multiple ...
Discover how CAR T cell therapy is breaking new ground in treating Multiple Sclerosis for the first time in the UK ...
Bionxt launched the final animal study needed to prepare for human testing of BNT23001, its under-the-tongue version of ...
A mum with multiple sclerosis has become the first patient in the UK to receive an experimental treatment that could slow or ...
News-Medical.Net on MSN
First multiple sclerosis patient in the UK receives CAR T cell therapy in groundbreaking trial
A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a ...
Watford Observer on MSN
Teacher first UK patient to receive ‘gamechanger’ therapy for MS
A biology teacher from Bushey has become the first patient in the UK to receive a “gamechanger” therapy to treat multiple ...
For people living with multiple sclerosis (MS), the search for effective treatment options can feel like a never-ending journey. While disease-modifying therapies (DMTs) have improved outcomes for ...
A UK MS patient is the first to receive CAR T-cell therapy, offering new hope to halt disease progression and reset the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback